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Abstract
Rationale—Skeletal muscle blood flow is coupled with the oxygenation state of hemoglobin in
young adults, whereby the erythrocyte functions as an oxygen sensor and releases ATP during
deoxygenation to evoke vasodilation. Whether this function is impaired in humans of advanced
age is unknown.
Objective—To test the hypothesis that older adults demonstrate impaired muscle blood flow and
lower intravascular ATP during conditions of erythrocyte deoxygenation.
Methods and Results—We show impaired forearm blood flow (FBF) responses during two
conditions of erythrocyte deoxygenation (systemic hypoxia and graded handgrip exercise) with
age, and this is due to reduced local vasodilation. In young adults, both hypoxia and exercise
significantly increased venous [ATP] and ATP effluent (FBF × [ATP]) draining skeletal muscle.
In contrast, hypoxia and exercise did not increase [ATP]v in older adults, and both [ATP]v and
ATP effluent were substantially reduced compared with young despite similar levels of
deoxygenation. Next, we demonstrate that this cannot be explained by augmented extracellular
ATP hydrolysis in whole blood with age. Finally, we found that deoxygenation-mediated ATP
release from isolated erythrocytes is essentially non-existent in older adults.
Conclusions—Skeletal muscle blood flow during conditions of erythrocyte deoxygenation is
markedly reduced in aging humans, and reductions in plasma ATP and erythrocyte-mediated ATP
release may be a novel mechanism underlying impaired vasodilation and oxygen delivery during
hypoxemia with advancing age. Because aging is associated with elevated risk of ischemic
cardiovascular disease and exercise intolerance, interventions targeting erythrocyte-mediated ATP
release may offer therapeutic potential.
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Evidence indicates a close coupling between skeletal muscle blood flow and the
oxygenation state of hemoglobin (Hb) in young healthy humans1, 2. In this respect, the
erythrocyte may function as an oxygen sensor in addition to an oxygen carrier and facilitate
local vasodilation in relation to the degree of unoccupied hemoglobin binding sites2–4. In
addition to the production of nitric oxide via deoxyhemoglobin-mediated nitrite reduction4
and the possible formation of S-nitrosohemoglobin5 during red blood cell deoxygenation,
ATP is also released from the red cell and likely contributes to local vasodilation observed
during mismatches in oxygen supply and demand2, 4, 6, 7. Specifically, during physiological
stimuli such as hypoxia and muscle contractions, ATP is believed to assist in the regulation
of blood flow and oxygen delivery to meet the metabolic demands of the tissue via binding
to purinergic (P2) receptors on the endothelium2, 7. Importantly and unique to ATP
vasomotor signaling in humans, we and others have demonstrated that exogenous ATP
administration evokes not only substantial vasodilation, but also blunts sympathetic
vasoconstriction in a dose-dependent fashion similar to what occurs in contracting
muscle8, 9. Moreover, because sympathoexcitation typically occurs during such
conditions10, 11, intravascular ATP is thought to have a critical role in blood flow regulation
in humans. Collectively, this schema provides a means of rapidly matching tissue oxygen
demand with oxygen delivery via alterations in arteriolar resistance as sensed by the red
blood cell oxygenation state.
While alterations in skeletal muscle vascular tone during conditions of Hb deoxygenation
have been determined in young healthy humans, little information exists in aging humans; a
population that demonstrates endothelial dysfunction as well as heightened sympathetic
activity and is at greater risk for ischemic cardiovascular diseases and exercise
intolerance12, 13. In this context, whether humans of advanced age have significantly
impaired blood flow control during conditions of Hb deoxygenation is unclear. Further,
whether this decline in local skeletal muscle vascular control and oxygen delivery with age
is related to the loss of circulating vasoactive ATP and more specifically, the loss of ATP
release from red blood cells during Hb deoxygenation is unknown. Therefore, we tested the
hypothesis that local control of skeletal muscle blood flow is impaired in aging humans
during systemic hypoxia as well as during muscle contractions (both conditions of
erythrocyte deoxygenation), and that plasma ATP of blood draining skeletal muscle is lower
in these conditions in older adults in vivo. Further, in an effort to gain mechanistic insight
underlying the diminished circulating ATP with human aging, we tested the hypothesis that
any age-associated impairment may be due in part to augmented ATP hydrolysis by blood
components and impaired release of ATP from the red blood cell during Hb deoxygenation
in vitro.
Methods
A detailed and expanded Methods section is available in the Online Data Supplement at
http://circres.ahajournals.org
Subjects
With Institutional Review Board approval and after written informed consent, a total of 37
young and 25 older healthy adults participated in the present investigation. This study was
approved by the Human Research Committee of Colorado State University and was
performed according to the Declaration of Helsinki.
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Experimental Protocols
Protocol 1: Forearm Plasma [ATP] during Intra-arterial ATP Infusion
Evidence in the lower limb indicates that ATP administered intra-arterially is undetectable
in the venous circulation2, 8, however the upper limb is a much smaller mass and less
distance is traveled for a single pass through the microcirculation. To establish that venous
plasma [ATP] measures (vs arterial) are most closely reflective of effluent draining skeletal
muscle, we determined whether: (a) plasma arterial [ATP] equates to plasma venous [ATP],
and (b) ATP is rapidly catabolized in a single passage of the forearm microcirculation. To
do so, we infused saline via brachial artery catheter for 3 minutes (control) followed by
infusion of ATP (8.35 nmol/dL/min) for 3 minutes in young adults. Blood was sampled
from both catheters at the end of saline and the deep venous catheter during ATP infusion
and analyzed for plasma [ATP] via the luciferin-luciferase technique. Arterial [ATP] during
infusion was calculated as: (8.35 nmol/dL/min × forearm volume)/forearm blood flow.
Protocol 2: Systemic Hypoxia and Age
An initial rest period of 3 min was given to establish baseline values while the subject
breathed on the mouthpiece open to room air. As previously described by our laboratory14,
the level of inspired O2 was then titrated to achieve an O2 saturation of ~80% as established
by pulse oximetry on the earlobe, while simultaneously clamping ETCO2 at baseline values
via self-regulating partial rebreathe system. This transition from baseline to the target level
of hypoxia typically occurred in 2 min. The subject was then maintained at ~80% for 5
minutes to establish steady-state levels of SpO2, ETCO2, as well as forearm hemodynamics
during hypoxia. Forearm blood flow (FBF; Doppler ultrasound14) and vascular conductance
(FVC) were calculated and venous blood was sampled for blood gases as well as plasma
[ATP] at the end of normoxia and the end of hypoxia.
Protocol 3: Graded Intensity Forearm Exercise and Age
After 3 minutes of baseline measurements, subjects performed dynamic rhythmic handgrip
exercise in the supine position with the non-dominant arm for a total of 15 minutes. This 15
minute trial was graded in exercise intensity whereby 5 minute segments each of 5, 15, and
25% maximum voluntary contraction (MVC) workloads were completed. FBF and FVC
were calculated and venous blood was sampled for blood gases as well as plasma [ATP] at
the end of rest and each exercise intensity level.
Protocol 4: ATP Hydrolysis in Whole Blood from Exercising Forearm and Age
Given the observations of reduced extracellular ATP in the blood of older adults during
exercise (see Results), we determined whether any observed age-associated differences in
venous plasma [ATP] were due to an enhanced capacity to degrade extracellular ATP within
the blood of older adults during exercise15, 16. To do so, subjects performed exercise as
described above in Protocol 3 and blood was sampled at the end of rest and each exercise
intensity level. Because data indicates that whole blood degrades ATP more rapidly than
plasma, and that blood cells such as leukocytes are a primary source for nucleotidase
activity, we determined the catabolism of 100 μM ATP in whole blood rather than plasma
alone17. In this respect, intraluminal extracellular ATP is exposed to the mixed media of
blood cells, and thus determination of ATP degradation in whole blood (vs plasma alone) is
a more accurate representation of ATP breakdown in vivo.
Protocol 5: Erythrocyte ATP Release during Hb Deoxygenation and Age
Given the collective observations of reduced extracellular ATP in the blood of older adults
during two conditions of Hb deoxygenation and that ATP is catabolized to a similar extent
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in young and older adults during exercise (see results), we aimed to determine whether the
release of ATP from erythrocytes of aging humans during low O2 exposure was impaired.
To do so, erythrocytes were diluted to 20% hematocrit and equilibrated with normoxic gas
(16% O2/6%CO2) for 15 minutes in a rotating bulb tonometer. The gas mixture was then
changed to 3% O2/6%CO2 mixture for 7 minutes followed by a secondary drop in O2 (1.5%/
6%CO2) for 7 more minutes. Our goal was to reduce PO2 and FO2Hb to levels within the
range observed in vivo. Red cells were sampled at the end of each gas equilibration period
and ATP was measured as described in the Online Data Supplement and normalized to red
cell count18, 19.
Data Acquisition and Analysis
Data was collected and stored on a computer at 250 Hz and analyzed off-line. Baseline FBF,
HR, and MAP represent an average of the last minute of the normoxic or resting time
period, and steady-state hyperemic values represent an average of the last 30 seconds of
each condition9. To account for changes in FBF and its impact on [ATP] concentration
measurements and to quantify the rate of total ATP draining the active muscle, ATP effluent
was calculated as FBF * [ATP]/1000, similar to other methods of data quantification when
blood flow is altered2, 20.
Statistics
All values are reported as means ± S.E.M. Specific hypothesis testing during hypoxia or
exercise studies across age was performed using two-way repeated measures ANOVA. In
the case of a significant F value, Student-Newman-Keuls post hoc pairwise comparisons
were made to identify significant differences. Comparison of the outcome variables at
specific time points between conditions were made with unpaired t-tests, and the values
within each condition with paired t-tests. SigmaPlot 11.0 (Systat Software, Inc., San Jose,
CA, USA) was used for all analysis and statistical significance was set a priori at P<0.05.
Results
Subject Characteristics
The mean age difference between the young and older adults was 41 years (23±1 vs 64±1
yrs). Older adults had a greater BMI, % body fat, total and LDL-cholesterol, and
triglycerides; however all measured variables were within the normal healthy range. All
subject characteristics are noted in Supplemental Table-IA. Additional characteristics of
those in Protocol 5 are presented in Supplemental Table-IB.
Protocol 1: Intra-arterial ATP Infusion in Young Adults
Exogenous ATP infusion in young adults (n=8) significantly increased arterial plasma
[ATP] compared to saline control (38±8 vs 956±148 nmol/L), however venous plasma
[ATP] was unchanged (52±13 vs 53±11 nmol/L) (Figure-1). Forearm and systemic
hemodynamics are presented in Supplemental Table-II. These data demonstrate elevations in
arterial plasma [ATP] without subsequent increases in venous plasma [ATP] supporting the
concept that extracellular ATP is rapidly degraded once in the circulation2, 17, 21. Given
these findings and the fact that the milieu (PO2, PCO2, pH) of venous blood is more closely
representative of the microcirculatory environment and conducive to ATP release, we
focused our investigation in aging humans to plasma [ATP] within venous blood draining
skeletal muscle.
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Protocol 2: Systemic Hypoxia and Age
The degree of systemic hypoxia was not different between young (n=10) and older (n=8)
adults (80.8±0.9 vs 81.5±0.9% SpO2) and ETCO2 was clamped at baseline (Supplemental
Table-III). FBF and FVC significantly increased during systemic hypoxia from normoxia in
young adults, but not in older adults (Figure-2A–B, Supplement Table-IIIB). MAP increased
in older adults in response to hypoxia, and absolute MAP was greater than young adults
(Supplemental Table-IIIB). Heart rate increased during systemic hypoxia in both groups,
however the response was lower in older adults (Supplemental Table-IIIB).
Venous plasma [ATP] was not different at rest between young and older adults (64±8 nmol/
L vs 47±10 nmol/L; Figure-2C). Young adults had significantly greater [ATP] during
hypoxia compared to normoxia (106±16 nmol/L; Δ 43±19 nmol/L; Figure-2C).
Remarkably, older adults had significantly lower [ATP] compared to young during hypoxia
and did not significantly increase [ATP] above rest (48±8 nmol/L; Δ 1±9 nmol/L;
Figure-2C). Similar to plasma [ATP], resting ATP effluent was not different with age.
During hypoxia, ATP effluent increased in young adults (2.6±0.7 vs 5.3±1 nmol/min;
Figure-2D), while there was no change in older adults (1.8±0.4 vs 1.7±0.3 nmol/min;
Figure-2D). Respiratory variables and venous blood gases are presented in Supplemental
Table-III.
Protocol 3: Graded Intensity Forearm Exercise and Age
FBF and FVC increased in a graded fashion during progressive handgrip exercise. Older
(n=12) compared to young (n=14) adults had significantly lower absolute FBF at 15 and
25% MVC exercise as well as significantly less forearm vasodilation (FVC) during all
exercise workloads (Figure-3A–B). HR and MAP increased in both young and older adults
in response to exercise, and absolute MAP was greater in older subjects (Supplemental
Table-IVB).
Venous plasma [ATP] was not different at rest between young and older adults (62±5 nmol/
L vs 59±9 nmol/L; Figure-3C). Young adults had significantly greater [ATP] during all
exercise intensities compared to rest conditions (5% = 96±13, 15% = 105±9, 25% = 126±12
nmol/L; Figure-3C). Older adults did not significantly increase [ATP] above rest and had
significantly lower [ATP] compared to young at all exercise intensities (5% = 52±7, 15% =
73±7, 25% = 83 ± 8 nmol/L; Figure-3C). ATP effluent was not different with age at rest
(young = 2.4±0.4 vs older = 2.0±0.3 nmol/min; Figure-3D). Although both young and older
adults had greater ATP effluent during exercise compared to rest, ATP effluent was
significantly attenuated ~50–60% with age (Figure-3D, Supplemental Figure-I). Venous
blood gases are presented in Supplement Table-V.
We measured arterial plasma [ATP] sampled from the brachial artery during exercise in 5
young adults who were instrumented with arterial catheters for other studies in the
laboratory. Arterial [ATP] was 34 ± 9 nmol/L at rest and 34 ± 6 nmol/L during 5% MVC
exercise. During 15 and 25% MVC exercise, arterial [ATP] was 44 ± 10 and 50 ± 4 nmol/L
(P = 0.2 vs rest), respectively. Importantly, arterial [ATP] at rest or during any exercise
intensity was always lower than the average resting venous [ATP] (~60 nmol/L;
Supplemental Figure-I), suggesting that arterial plasma [ATP] detectable at the brachial
artery does not increase in this model of exercise and further, is not explanatory for
elevations in venous plasma [ATP] resultant from exercise nor the age-group differences
found in this Protocol.
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Protocol 4: ATP Hydrolysis in Whole Blood from Exercising Forearm and Age
The % of ATP remaining of 100 μM ATP in whole blood was significantly lower from the
previous time point of measurement indicating rapid and progressive ATP degradation over
time within whole blood in young (n=8) and older (n=8) adults (P<0.05; Figure-4A–E).
There were no age-group differences in ATP hydrolysis at any exercise intensity or
timepoint. At minute 15, the % of ATP remaining was lower at all exercise intensities
compared to rest for all subjects (P<0.05), indicating that acute exercise augments ATP
catabolism in whole blood.
Protocol 5: Erythrocyte ATP Release during Hb Deoxygenation and Age
Erythrocytes from young (n=8) and older (n=8) adults were similarly deoxygenated when
exposed to 3% O2 and 1.5% O2 compared to 16% O2 normoxic gas (Supplemental Table-
V). PO2, PCO2, and pH were not different between age-groups during normoxic and
hypoxic gas exposure.
Absolute ATP release from red cells of young adults tended to increase during the first level
of hypoxia (P = 0.087) and was significantly elevated during the second level of hypoxia
(Figure-5A). The relative (%) change in ATP from baseline was graded with the level of
deoxygenation. In contrast, red blood cells of older adults did not release ATP at either level
of deoxygenation, and a clear age-associated impairment was observed during the second
level of hypoxia (205±57 vs 43±24%; Figure-5B).
Discussion
To the best of our knowledge, this is the first study to directly investigate alterations in
extracellular intravascular ATP in aging humans and the control of blood flow and vascular
tone at rest or during Hb deoxygenating stimuli such as systemic hypoxia and exercise.
There are several new findings from the present series of in vivo and in vitro experiments.
First, despite an augmented perfusion pressure in older adults, skeletal muscle blood flow
during conditions of erythrocyte deoxygenation (systemic hypoxia and exercise) is markedly
reduced in aging humans due to impaired local vasodilation. Second, while venous plasma
[ATP] increases during systemic hypoxia and during dynamic forearm exercise in young
adults, healthy older humans do not increase [ATP] and have significantly lower [ATP] than
young adults under these conditions. Third, the rate of ATP effluent from skeletal muscle
increases during systemic hypoxia and graded intensity forearm exercise in young adults,
whereas no increase in ATP effluent is observed during hypoxia in older adults and the
increase is substantially blunted during exercise (~50–65% vs young; Figure-6).
Importantly, the reduced [ATP] and ATP effluent in older adults occurs concomitantly with
less vasodilation. Fourth, although extracellular ATP is rapidly degraded within the human
circulation and this catabolism is enhanced by exercise, aging does not appear to augment
ATP hydrolysis in whole blood at rest or during exercise. Finally, release of ATP from
erythrocytes of older adults in response to deoxygenation is markedly impaired and these
data are the first evidence of such impairment in aging humans. Collectively, reductions in
erythrocyte-mediated ATP release and intravascular ATP may be a novel mechanism by
which skeletal muscle blood flow and oxygen delivery is impaired during hypoxemia with
advancing age in humans.
Aging, Blood Flow, and Intravascular ATP during Conditions of Hb Deoxygenation (in vivo
studies)
Evidence indicates a close coupling between skeletal muscle blood flow and the
oxygenation state of Hb1, and deoxygenation-mediated ATP release from red blood cells is
believed to have a role in this coupling by evoking local vasodilation via binding to P2
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receptors on the endothelium. Intravascular ATP evokes a robust endothelium-dependent
vasodilation and also can blunt sympathetically-mediated vasoconstriction in young healthy
humans, both which will serve to improve blood flow and oxygen delivery to hypoxic or
metabolically-active tissue. Because aging is classically associated with endothelial
dysfunction22 and older adults present with an impaired ability to modulate sympathetic
vasoconstriction in contracting muscle (“functional sympatholysis”)23, we recently directly
tested whether these unique properties of ATP were impaired with age. In contrast to our
hypotheses, older adults demonstrated preserved ATP-mediated vasodilation and the ability
to blunt sympathetic α-adrenergic vasoconstriction23, 24. These collective observations
suggest that if ATP is involved in the impairment of vascular control during mismatches in
oxygen supply and demand in aging humans, older adults are likely to have diminished
intravascular ATP during conditions of Hb deoxygenation.
The findings from Protocol 2 in the present investigation are the first to demonstrate an age-
related impairment in the local vasodilation and muscle blood flow response to systemic
isocapnic hypoxia in humans (SPO2 ~80%). Specifically, while local vascular conductance
increases in young adults during systemic hypoxia, this is essentially non-existent in older
adults (Figure-2B). In line with our central hypothesis, plasma [ATP] and ATP effluent
increases during systemic hypoxia in young, however we observed no significant change in
either indices of vasoactive ATP in aged humans (Figure-2C–D). This absence of local
vasodilation in conjunction with a lack of net ATP release in vivo in older adults is
consistent with prior in vitro studies demonstrating that red blood cells are crucial to observe
hypoxic vasodilation4, 5, 7, 18, and within the present study, implicate the loss of vasoactive
ATP as a potential mechanism.
The findings from Protocol 3 are consistent with many studies in older adults demonstrating
that local vascular conductance (vasodilation) is impaired and thus muscle blood flow
during exercise is reduced despite an augmented perfusion with age22, 25. However, whether
age-associated reductions in exercise hyperemia and oxygen delivery are associated with
lower levels of intravascular ATP has never been determined. In young subjects, mild
contractions (5% MVC) evoked a significant increase in plasma [ATP] which was
maintained during 15% MVC and increased further during 25% MVC exercise. In contrast,
despite similar levels at rest, plasma [ATP] did not increase above baseline values in older
subjects during any exercise intensity and these concentrations were significantly lower
compared with the young. Somewhat similarly, ATP effluent increased progressively with
exercise intensity in both young and older adults, however ATP effluent was significantly
lower in older adults at every exercise intensity (~50–65%). As in Protocol 2, we clearly
show that older adults have significantly lower muscle blood flow during exercise which
occurs concomitantly with less plasma [ATP] and ATP effluent. Although the mechanism
underlying these impairments in hyperemia and oxygen delivery with age may be somewhat
dependent on the stimulus, our collective data imply that blunted vasodilation with age
during two physiological conditions of erythrocyte deoxygenation may be due, in part, to
reductions in intravascular ATP. In turn, this could lead to reductions in P2 receptor
stimulation and reduced endothelium-dependent signaling for direct vasodilation and/or the
modulation of sympathetic vasoconstriction and thus impaired control of peripheral vascular
tone in aged humans10, 22, 23.
Potential Mechanisms for Attenuated Plasma [ATP] with Age during Conditions of Hb
Deoxygenation (in vitro studies)
Evidence indicates that ATP catabolism to downstream metabolites occurs rapidly within
whole blood17, and that this process is enhanced during exercise15 and in humans that
demonstrate endothelial dysfunction16. We recently observed under resting conditions that
vasodilation evoked via exogenous ATP infusions does not occur via P1-receptors in both
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young and older adults, providing indirect evidence that nucleotidase activity is not
augmented with age at rest24. However, whether ATP catabolism is augmented during
exercise with human aging (independent of other co-morbidities) and could in part explain
the reduced ATP levels we observed in circulation of older adults during exercise is
unknown. Therefore, we directly determined ATP degradation in whole blood at rest and
during exercise. We found no evidence of augmented ATP breakdown in blood of older vs
young adults sampled at rest or during exercise. Nevertheless, our data support the concept
that ATP hydrolysis is greater during conditions of exercise (Figure-4E)15. It should be
noted here that an [ATP] greater than that observed in our samples was used for the ATP
degradation assay similar to previous reports16, 17, therefore true in vivo catabolism rates
cannot be extrapolated from our findings. However, in light of our observations, we
speculate that the reduced intravascular ATP during hypoxia and exercise in aging humans
may result from either augmented breakdown via endothelial cell bound nucleotidases
(which is not accounted for in our catabolism studies) or a loss of ATP production and/or
efflux of extracellular ATP into circulation.
Studies in isolated red blood cells have clearly demonstrated that Hb deoxygenation evokes
ATP release that is graded with the level of deoxygenation3. Therefore, in an effort to reveal
a possible mechanism underlying our in vivo observations, we determined whether ATP
release from erythrocytes of healthy older adult humans was impaired compared to red cells
of healthy young adults. By study design, we focused on deoxygenating erythrocytes to
FO2Hb levels similar to our in vivo measures. In support of this hypothesis, we observed
that ATP release from red blood cells of young adults increased by 71% from baseline
normoxia (FO2Hb = ~95%) during first level of low oxygen exposure (FO2Hb = ~71%) and
by 205% during the second level (FO2Hb = ~43%). In contrast, red cells from older adults
did not significantly release ATP during either low oxygen condition despite similar total
intracellular [ATP] and a clear age-impairment was present (Figure-5). Although it is
currently unclear why this impairment exists, these data are consistent with observations
from red cells of diabetic patients that demonstrate blunted ATP release and subsequent
vasodilation compared to red cells of healthy adults18. Interestingly, deoxygenation-induced
ATP release is significantly impaired from red cells of poor deformability26, and reduced
erythrocyte deformability occurs with advanced donor age27. Therefore, it is plausible to
speculate that our observed ‘erythrocyte dysfunction’ may be secondary to red cell stiffening
with advancing age. Nonetheless, it is apparent that red blood cells from humans of
advanced age fail to release ATP during Hb deoxygenation, and this is likely one
mechanism underlying the age-related reduction in plasma [ATP] and vasodilation during
hypoxemia with age. Although not directly established in our in vivo studies, data obtained
in vitro clearly demonstrate that blunted ATP release from red cells is associated with
impaired vasomotor responses, and importantly that vasodilation can be restored when ATP
release from red cells is rescued18.
Integrative Perspectives
We utilized several in vivo and in vitro experimental approaches to gain an understanding of
whether intravascular ATP is impaired in aging humans during physiological conditions of
Hb deoxygenation and, if so, what potential mechanisms are involved. The concept that the
red blood cell can serve as an oxygen carrier and sensor is certainly intriguing, however this
leads to complex physiology and associated measures in vivo particularly during conditions
of high blood flow within contracting skeletal muscle. One important consideration under
these experimental conditions relates to the measurement of plasma [ATP] as solely
representing the available circulating vasoactive ATP. In our experiments, there is a clear
increase in [ATP] in young adults during 5% MVC exercise which did not increase
significantly above this level until 25% MVC (Figure-3A). Because total muscle blood flow
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(and hence blood volume) increased up to 10-fold during exercise, this means that a
significant release of ATP release into circulation must occur otherwise [ATP] would
decrease via dilution effect by the large volume of blood. This latter point has recently been
demonstrated experimentally during high flow non-exercise conditions (acetylcholine
infusions) in humans28. Thus, although plasma [ATP] may represent one measure of
intravascular ATP, we believe that quantification of ATP effluent ([ATP] × flow) may be
important as well to describe the total circulating rate of vasoactive ATP available to evoke
vasodilation during a given stimulus2. Accordingly, we have summarized ATP effluent
across all in vivo conditions in the present study and demonstrate that although this is
normal under resting conditions in older adults, ATP effluent during systemic hypoxia is
abolished and during forearm exercise is substantially reduced with age (Figure-6).
A second point relates to the influence of elevated blood flow due to vasodilation and the
number of red blood cells exposed to the low oxygen environments of systemic hypoxia and
exercise, as total released ATP is dependent on the number of red cells19, 29. By means of
the Fahraeus and Phase Separation effects, vasodilation increases red cell supply and
microvascular hematocrit7, 30. This is important in that during exercise, PO2 and Hb
oxygenation within skeletal muscle significantly decrease at the onset of low intensity
exercise and remain relatively constant as exercise intensity increases2, 31 (see Supplemental
Table-IVA). However, given the elevation in total muscle blood flow, redistribution of
blood to the active muscle fibers, and elevations in microvascular hematocrit, the total
number of red cells exposed to the low oxygen environment is significantly elevated
providing a greater stimulus for net ATP release in vivo. Further, the integrative
physiological conditions of contracting muscle not only results in Hb deoxygenation, but
also evokes changes in pH, CO2, as well as mechanical stresses all of which can induce
extracellular ATP release from erythrocytes into circulation2, 6, 7, 32. Thus, within skeletal
muscle, a simple correlation between Hb deoxygenation and [ATP] in vivo does not exist
nor should it be requisite to exist to support this overall hypothesized regulation of tissue
blood flow and oxygen delivery by the red cells. A final consideration regarding the
complexity of this physiology is the ability of endothelial cell bound ectonucleotidases21 as
well as other blood constituents to rapidly degrade ATP in vivo, the latter of which have
been shown to be upregulated during exercise15 (Figure-4E). This very tight regulation
between red cell delivery, ATP release, and ATP degradation may aid in explaining why
venous plasma [ATP] are not substantially greater as exercise intensity and blood flow is
increased even in young adults.
Experimental Considerations
First, there are multiple sources of ATP including sympathetic nerve terminals as well as
skeletal muscle. However, recent studies have demonstrated that ATP does not cross the
endothelium2, 28, 33, and thus intravascular [ATP] from these sources is unlikely. Further,
older adults demonstrate greater levels of sympathetic activity both at rest and during
conditions of deoxygenation10, 11 and the exercise intensity and forearm muscle mass was
similar between groups; thus these cannot explain the reductions in intravascular ATP with
age.
Second, to definitively determine the contribution of intravascular ATP to vasomotor control
during systemic hypoxia and exercise, the use of a specific P2Y receptor antagonist would be
ideal. Unfortunately, agents used in animal preparations in vivo are significantly flawed34
and no substances are currently approved for human use. Regardless, the loss of ATP release
from red cells has been repeatedly linked with impaired vascular function and lends
credibility to our in vivo and in vitro observations4, 5, 7, 18, 35, 36. Independent from vascular
control, ATP as a signaling molecule has a wide range of effects on cardiovascular function.
Profoundly, attenuated intravascular ATP is associated with a pro-thrombotic environment,
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leukocyte adhesion, platelet activation, enhanced ischemia-reperfusion injury, and hyper-
inflammation37. Therefore, the present observations of diminished intravascular ATP in
humans of advanced age have clear implications and therapeutic potential for many
cardiovascular complications in addition to oxygen delivery during hypoxemia.
Third, in the present in vivo aging experiments we did not sample for arterial plasma [ATP].
However, studies in young subjects demonstrated that arterial infusion of ATP is not
detectable in the venous blood of the same limb (Figure-1) and that arterial [ATP] is lower
than venous values and does not increase during handgrip exercise (Supplemental Figure-I).
Finally, a wealth of data exists demonstrating no significant elevation in arterial plasma
[ATP] during systemic hypoxia, or in response to exercise (e.g.38). Thus, these data are
consistent with our observations that arterial plasma [ATP] is not explanatory of venous
plasma [ATP] nor the observed impairments with age.
Fourth, blood flow regulation to contracting muscle is complex and involves many factors in
addition to intravascular ATP such as K+ efflux from myocytes, mechanical factors, as well
as a variety of endothelial and metabolically-derived substances39. In this context, we show
a robust association between plasma ATP and forearm blood flow (Figure-3E) that is left-
shifted in older adults and likely depicts a compensation of lowered plasma [ATP] by other
vasodilatory signals, rather than enhanced ATP receptor responsiveness23, 24. Thus, despite
clear impairments in intravascular ATP and hyperemic responses during exercise in older
subjects, blood flow still increases during exercise and this would be expected given the
redundant control of blood flow to active muscle.
Conclusions
In young healthy humans, oxygen delivery is effectively matched to oxygen demand during
hypoxia and exercise via increases in skeletal muscle blood flow; however, older adults
demonstrate an altered control of the vasculature (impaired vasodilation and functional
sympatholysis) that may predispose this population to increased risk for ischemia related
cardiovascular disease and exercise intolerance12, 13. The collective findings from the
present investigation indicate that skeletal muscle blood flow during conditions of
erythrocyte deoxygenation is markedly reduced in aging humans due to impaired local
vasodilation associated with reductions in plasma ATP. Further, we suggest that loss of
erythrocyte-mediated ATP release may be a novel mechanism underlying impaired oxygen
delivery during hypoxemia with advancing age, and that rectification of this dysfunction
could prove beneficial for older healthy and diseased humans.
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Non-standard Abbreviations
ATP adenosine triphosphate
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BMI body mass index
ctO2 oxygen content
ctCO2 carbon dioxide content
DEXA dual-energy X-ray absorptiometry
ETCO2 end-tidal carbon dioxide
FBF forearm blood flow
FO2Hb fraction of oxyhemoglobin
FVC forearm vascular conductance
HCT hematocrit
HDL high-density lipoprotein
Hb hemoglobin
HbA1C glycated hemoglobin
LDL low-density lipoprotein
MAP mean arterial pressure
MBV mean blood velocity
MVC maximal voluntary contraction
PO2 partial pressure of oxygen
PCO2 partial pressure of carbon dioxide
RBC red blood cell
RLU relative light units
SpO2 oxygen saturation-pulse oximetry
tHb total hemoglobin
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NOVELTY AND SIGNFICANCE
What is Known?
• Human aging is a predominant risk factor for ischemia-related cardiovascular
events.
• Blood flow in the muscle is closely coupled to the oxygenation state of
hemoglobin in young healthy humans.
• Intravascular ATP in the extracellular space has potent vasoactive properties and
is released from erythrocytes.
What New Information Does This Article Contribute?
• Skeletal muscle blood flow is markedly reduced in humans of advanced age
during conditions of erythrocyte deoxygenation due to impaired local
vasodilation.
• Unlike young adults, intravascular plasma [ATP] does not increase during
conditions of erythrocyte deoxygenation in older adults.
• While ATP hydrolysis by blood is augmented during exercise, aging does not
alter this capacity.
• Red blood cells from humans of advanced age are significantly impaired in their
ability to release ATP during hemoglobin deoxygenation.
Aging is associated with endothelial dysfunction as well as heightened sympathetic
activity and it increases the risk for ischemic cardiovascular diseases and exercise
intolerance. Nevertheless, it is unclear whether a decline in local skeletal muscle vascular
control and oxygen delivery with age is related to the loss of circulating vasoactive ATP
and more specifically, the loss of ATP release from red blood cells during Hb
deoxygenation Here, we present evidence supporting the notion that skeletal muscle
blood flow, local vasodilation, intravascular plasma ATP, and erythrocyte-mediated ATP
release during conditions of erythrocyte deoxygenation are markedly impaired in aged
humans. This ‘erythrocyte dysfunction’ may be a novel mechanism underlying impaired
vasodilation and oxygen delivery during hypoxemia with advancing age. Because aging
is associated with elevated risk for ischemic cardiovascular disease as well as exercise
intolerance, and ATP has notable effects on vascular function, interventions to improve
erythrocyte-mediated ATP release may of therapeutic value.
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Figure 1. Lack of Increase in Venous Plasma [ATP] During Intra-arterial ATP Infusion
ATP was infused intra-arterially through the brachial artery at a dose of 8.35 nmol/dL/min
for 3 minutes in young adults. Calculated arterial plasma ATP was significantly elevated
during drug infusion, while measured venous plasma ATP was unchanged. * P < 0.05 vs
saline.
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Figure 2. A–D. Forearm Hemodynamic Responses and Plasma ATP during Systemic Hypoxia
with Age
(A) Forearm blood flow (FBF), (B) forearm vasodilation (FVC), (C) plasma [ATP]V, and
(D) ATP effluent significantly increased during systemic hypoxia from normoxia in young
adults, but this was not observed in older adults. Older adults had significantly lower FBF,
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FVC, plasma [ATP]V, and ATP effluent during systemic hypoxia compared to young adults.
* P < 0.05 vs normoxia; † P < 0.05 vs young.
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Figure 3. A–E. Forearm Hemodynamic Responses and Plasma ATP Measures during Graded
Intensity Rhythmic Handgrip Exercise with Age
(A) Forearm blood flow (FBF) and (B) forearm vasodilation (FVC) increased as result of
exercise despite age. However, older adults had lower FBF at 15 and 25% MVC, and FVC
was lower at all intensities. (C) Plasma [ATP]v was elevated during exercise from rest in
young adults but not older adults, and aged humans had significantly lower values at all
exercise intensities. (D) ATP effluent was increased from rest during all intensities in young
and older adults, yet a markedly blunted response was observed with age. (E) Association
between venous plasma [ATP] and FBF at rest and during exercise. * P < 0.05 vs rest; † P <
0.05 vs young; ‡ P<0.05 vs 5% and 15% MVC within young.
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Figure 4. A–E. Hydrolysis of ATP in Whole Blood Acquired During Graded Rhythmic Handgrip
Exercise
Exogenous ATP (100 μM) was progressively catabolized in human whole blood samples
over 15 minutes at all exercise intensities. No difference with age at rest or across exercise
intensities was observed when % ATP remaining was determined (A) Rest, (B) 5% MVC,
(C) 15% MVC, (D) 25% MVC. (E) ATP hydrolysis (after 15 minutes) was significantly
greater than rest during exercise for all subjects, but was not dependent on intensity. * P
<0.05 vs prior time point. ‡ P<0.05 vs rest.
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Figure 5. Deoxygenation-Induced ATP Release from Isolated Erythrocytes of Young and Older
Adult Humans
(A) ATP release tended to increase from red blood cells of young adults during 3% O2 (P
=0.087; PO2 = 46±1 mmHg), and significantly increased during 1.5% O2 (PO2 = 28±1
mmHg), but no increase occurred from red cells of older adults. (B) The percent increase in
ATP release was significant from red blood cells of young adults during both levels of
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hypoxia, however this was not observed from red cells of older adults. * P < 0.05 vs
normoxia (16% O2; PO2 = 110±2 mmHg); † P < 0.05 vs young; ‡ P < 0.05 vs zero.
Kirby et al. Page 26
Circ Res. Author manuscript; available in PMC 2013 July 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6. Summary of ATP Effluent Across Conditions in Young and Older Adults
ATP effluent was calculated for each experimental condition based on [ATP]v and forearm
blood flow. ATP effluent for baseline is the combined average of baseline values prior to
hypoxia and exercise trials and was not different with age. ATP effluent in young adults
(black) was significantly increased during hypoxia (~80% O2 saturations) alone and during
exercise. Older adults did not increase ATP effluent during hypoxia but did during exercise.
An age-associated reduction in ATP effluent was observed for all experimental conditions of
hypoxia alone and exercise. (A). * P < 0.05 vs rest; † P < 0.05 vs young. MVC = maximum
voluntary contraction
Kirby et al. Page 27
Circ Res. Author manuscript; available in PMC 2013 July 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
